Direct Biologics
phase pivotal trial design and path to approval | Direct Biologics
Company
Deck Type
Deck date
October 2022
Slide
19 of 36
Related slides by other companies
Valneva
IPO
April 2021
development outlook pivotal phase trial initiated | Valneva
AstraZeneca
Results
February 2024
investing in new launches near and mid term pipeline phase trials initiated across medicines phase trials initiated with blockbuster potential regulatory approvals in major markets new medicines approved and on track to deliver on ambition for at least launches by | AstraZeneca
Aeglea BioTherapeutics
Investor Presentation
June 2020
pivotal phase peace trial design | Aeglea BioTherapeutics
Chimerix
Investor Presentation
March 2023
pivotal phase action trial design primary overall survival day | Chimerix
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights